Attached files
| file | filename |
|---|---|
| EX-10.36 - EXHIBIT 10.36 - Cardiovascular Systems Inc | ex1036-executiveseverancep.htm |
| EX-10.48 - EXHIBIT 10.48 - Cardiovascular Systems Inc | ex1048-2014equityplanperfo.htm |
| EX-10.45 - EXHIBIT 10.45 - Cardiovascular Systems Inc | ex1045-thatcherseparationa.htm |
| EX-10.49 - EXHIBIT 10.49 - Cardiovascular Systems Inc | ex1049-csiperformancexvest.htm |
| EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Inc | ex321-63016.htm |
| EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Inc | ex322-63016.htm |
| EX-10.7 - EXHIBIT 10.7 - Cardiovascular Systems Inc | ex107-fy17directorcomp.htm |
| EX-10.50 - EXHIBIT 10.50 - Cardiovascular Systems Inc | ex1050-employmentagreement.htm |
| EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Inc | ex312-63016.htm |
| EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Inc | ex311-63016.htm |
| EX-10.6 - EXHIBIT 10.6 - Cardiovascular Systems Inc | ex106-fy17execincentiveplan.htm |
| 10-K - 10-K - Cardiovascular Systems Inc | csii10-kx63016.htm |
| EX-10.5 - EXHIBIT 10.5 - Cardiovascular Systems Inc | ex105-fy17basesalaries.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-158755, 333-160609, 333-168682, 333-175703, 333-182668, 333-189856, 333-197348, 333-200214, and 333-208137) of Cardiovascular Systems, Inc. of our report dated August 25, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
August 25, 2016